{"id":2622,"date":"2019-10-21T20:34:44","date_gmt":"2019-10-22T00:34:44","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/the-irish-times-us-opioid-epidemic-the-260m-settlement\/"},"modified":"2022-06-27T02:33:34","modified_gmt":"2022-06-27T06:33:34","slug":"the-irish-times-us-opioid-epidemia-the-260m-settlement","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/es\/libros-blancos\/the-irish-times-us-opioid-epidemia-the-260m-settlement\/","title":{"rendered":"The Irish Times: Epidemia de opioides en EE. UU. y el acuerdo $260m"},"content":{"rendered":"<p>Four large drug companies reached a last-minute $260 million (\u20ac233 million) legal settlement over their role in the US opioid addiction epidemic, averting the first federal trial, which was scheduled to start on Monday morning in Cleveland, Ohio.<\/p>\n<p>The settlement covers drug distributors AmerisourceBergen, Cardinal Health and McKesson and Israel-based drugmake Teva Pharmaceutical Industries, and ends lawsuits by two Ohio counties.<\/p>\n<p>Hunter Shkolnik, an attorney for the counties, said Teva was paying $20 million in cash and would contribute $25 million worth of Suboxone, an opioid addiction treatment.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cuatro grandes compa\u00f1\u00edas farmac\u00e9uticas llegaron a un acuerdo legal de \u00faltima hora de $260 millones (\u20ac233 millones) por su papel en la epidemia de adicci\u00f3n a los opi\u00e1ceos en EE. UU., evitando el primer juicio federal, que estaba programado...<\/p>","protected":false},"featured_media":0,"menu_order":261,"template":"","whitepaper_category":[75,98,253,254],"whitepaper-source":[316],"class_list":["post-2622","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-the-irish-times"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepapers\/2622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepapers\/2622\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/media?parent=2622"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepaper_category?post=2622"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepaper-source?post=2622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}